| Chitosans for gene delivery G Borchard Advanced drug delivery reviews 52 (2), 145-150, 2001 | 744 | 2001 |
| Chitosan and its derivatives in mucosal drug and vaccine delivery IM Van der Lubben, JC Verhoef, G Borchard, HE Junginger European Journal of Pharmaceutical Sciences 14 (3), 201-207, 2001 | 661 | 2001 |
| Chitosan as a starting material for wound healing applications V Patrulea, V Ostafe, G Borchard, O Jordan European Journal of Pharmaceutics and Biopharmaceutics 97, 417-426, 2015 | 640 | 2015 |
| Nanomedicines: addressing the scientific and regulatory gap S Tinkle, SE McNeil, S Mühlebach, R Bawa, G Borchard, Y Barenholz, ... Annals of the New York Academy of Sciences 1313 (1), 35-56, 2014 | 591 | 2014 |
| Preparation and characterization of protein-loaded N-trimethyl chitosan nanoparticles as nasal delivery system M Amidi, SG Romeijn, G Borchard, HE Junginger, WE Hennink, W Jiskoot Journal of controlled release 111 (1-2), 107-116, 2006 | 524 | 2006 |
| The potential of mucoadhesive polymers in enhancing intestinal peptide drug absorption. III: Effects of chitosan-glutamate and carbomer on epithelial tight junctions in vitro G Borchard, HL Lueβen, AG de Boer, JC Verhoef, CM Lehr, HE Junginger Journal of controlled release 39 (2-3), 131-138, 1996 | 523 | 1996 |
| Quaternized chitosan oligomers as novel gene delivery vectors in epithelial cell lines M Thanou, BI Florea, M Geldof, HE Junginger, G Borchard Biomaterials 23 (1), 153-159, 2002 | 517 | 2002 |
| Chitosan for mucosal vaccination IM Van der Lubben, JC Verhoef, G Borchard, HE Junginger Advanced drug delivery reviews 52 (2), 139-144, 2001 | 506 | 2001 |
| Chitosan microparticles for oral vaccination:: preparation, characterization and preliminary in vivo uptake studies in murine Peyer's patches IM Van der Lubben, JC Verhoef, AC Van Aelst, G Borchard, HE Junginger Biomaterials 22 (7), 687-694, 2001 | 369 | 2001 |
| PLGA–PEI nanoparticles for gene delivery to pulmonary epithelium M Bivas-Benita, S Romeijn, HE Junginger, G Borchard European Journal of Pharmaceutics and Biopharmaceutics 58 (1), 1-6, 2004 | 320 | 2004 |
| Transfection efficiency and toxicity of polyethylenimine in differentiated Calu-3 and nondifferentiated COS-1 cell cultures BI Florea, C Meaney, HE Junginger, G Borchard Aaps Pharmsci 4, 1-11, 2002 | 308 | 2002 |
| Preparation of coated nanoparticles for a new mucosal vaccine delivery system O Borges, G Borchard, JC Verhoef, A de Sousa, HE Junginger International journal of pharmaceutics 299 (1-2), 155-166, 2005 | 299 | 2005 |
| Pulmonary delivery of chitosan-DNA nanoparticles enhances the immunogenicity of a DNA vaccine encoding HLA-A* 0201-restricted T-cell epitopes of Mycobacterium tuberculosis M Bivas-Benita, KE van Meijgaarden, KLMC Franken, HE Junginger, ... Vaccine 22 (13-14), 1609-1615, 2004 | 243 | 2004 |
| Uptake studies in rat Peyer's patches, cytotoxicity and release studies of alginate coated chitosan nanoparticles for mucosal vaccination O Borges, A Cordeiro-da-Silva, SG Romeijn, M Amidi, A de Sousa, ... Journal of Controlled Release 114 (3), 348-358, 2006 | 242 | 2006 |
| Non-invasive pulmonary aerosol delivery in mice by the endotracheal route M Bivas-Benita, R Zwier, HE Junginger, G Borchard European Journal of Pharmaceutics and Biopharmaceutics 61 (3), 214-218, 2005 | 242 | 2005 |
| Preparation and NMR characterization of superporous hydrogels (SPH) and SPH composites FA Dorkoosh, J Brussee, JC Verhoef, G Borchard, M Rafiee-Tehrani, ... Polymer 41 (23), 8213-8220, 2000 | 208 | 2000 |
| Inhaled drug therapy for treatment of tuberculosis A Misra, AJ Hickey, C Rossi, G Borchard, H Terada, K Makino, PB Fourie, ... Tuberculosis 91 (1), 71-81, 2011 | 202 | 2011 |
| Mucoadhesive polymers in peroral peptide drug delivery. II. Carbomer and polycarbophil are potent inhibitors of the intestinal proteolytic enzyme trypsin HL Lueßen, JC Verhoef, G Borchard, CM Lehr, AG De Boer, ... Pharmaceutical research 12, 1293-1298, 1995 | 200 | 1995 |
| Immune response by nasal delivery of hepatitis B surface antigen and codelivery of a CpG ODN in alginate coated chitosan nanoparticles O Borges, A Cordeiro-da-Silva, J Tavares, N Santarém, A de Sousa, ... European journal of pharmaceutics and biopharmaceutics 69 (2), 405-416, 2008 | 199 | 2008 |
| Evaluation of the immune response following a short oral vaccination schedule with hepatitis B antigen encapsulated into alginate-coated chitosan nanoparticles O Borges, J Tavares, A de Sousa, G Borchard, HE Junginger, ... european journal of pharmaceutical sciences 32 (4-5), 278-290, 2007 | 185 | 2007 |
Olivier JordanSenior lecturer, University of GenevaAdresse e-mail validée de unige.ch
